The journal Regenerative Medicine has announced the promotion of Dr Chris Mason to Senior Editor. Dr Mason succeeds Dr Stephen Minger who has steered the journal since its launch in January 2006.
Dr Chris Mason (University College London) is internationally recognized to be at the forefront of the emerging field of stem cell and regenerative medicine translation and commercialization. A background in basic science, clinical medicine, bioprocessing and business has given Dr Mason a unique insight and understanding of the challenges facing the regen sector as it grows into a competitive and sustainable global healthcare industry.
Elisa Manzotti, Editorial Director of Future Medicine thanked the outgoing Senior Editor, "We owe profound thanks to Dr Minger. Under his wing, Regenerative Medicine has rapidly become the premier forum for the fast growing community of specialist stakeholders who address the complex challenge of translating and commercializing stem cell and regenerative medicine research into routine clinical practice."
Regenerative Medicine won the 2006 ALPSP/Charlesworth Award Best New Journal award from The Association of Learned and Professional Society Publishers. The journal is covered by the major abstracting and indexing databases, including MEDLINE, ISI Science Citation Index Expanded (SciSearch®), ISI Biotechnology Citation Index®, ISI Journal Citation Reports/Science, EMBASE and Scopus.